CVE-2026-40435 BIG-IP httpd access control vulnerability
Attackers from blocked IP addresses can bypass httpd access restrictions on BIG-IP devices when specific configurations are enabled.
- Exploited in the wild
- Not known
- Login needed
- Not needed
- Attackable
- Over the internet
- Victim action needed
- Not needed
- Fix
- None listed
What is CVE-2026-40435?
CVE-2026-40435 is a medium-severity missing authorization vulnerability in F5 Big-Ip Access Policy Manager, published on 13 May 2026. An attacker can exploit it over the internet without logging in, with no action from the victim.
Official description
When configured, IP-based access restrictions for httpd do not cover all endpoints, which may allow connections from blocked addresses. Note: Software versions which have reached End of Technical Support (EoTS) are not evaluated.
Weakness: CWE-420
Which versions are affected by CVE-2026-40435?
It affects 21 products.
Products include F5 Big-Ip Access Policy Manager, F5 Big-Ip Advanced Firewall Manager, F5 Big-Ip Advanced Web Application Firewall, F5 Big-Ip Analytics, F5 Big-Ip Application Acceleration Manager, F5 Big-Ip Application Security Manager and 15 more.
How do I fix CVE-2026-40435?
No fix has been published for CVE-2026-40435 yet. Limit exposure of the affected software until one is available.
Upgrade, and check permissions on every request on the server, not only in the interface. More about Missing authorization.
Is CVE-2026-40435 being exploited?
There is no known exploitation of CVE-2026-40435 in the wild and no public exploit code.
Other vulnerabilities in F5 Big-Ip Access Policy Manager
- CVE-2023-46747 F5 BIG-IP Configuration Utility Authentication Bypass
- CVE-2022-1388 F5 BIG-IP Missing Authentication
- CVE-2021-22986 F5 BIG-IP and BIG-IQ Centralized Management iControl REST Remote Code Execution
- CVE-2021-22991 F5 BIG-IP Traffic Management Microkernel Buffer Overflow
- CVE-2020-5902 F5 BIG-IP Traffic Management User Interface (TMUI) Remote Code Execution
Sources
Also known as GHSA-8463-7qgv-32mg.